TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00086684

Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis

Cause of deathFutility Automatic label, confidence 0.9, unverified. How labels are made.
“Interim Analysis showed that study continuation was futile. No safety concerns were raised during the trial.”

The sponsor’s own words in the registry.

Life of this trial

20032004200520062007200820092010201120122013Started2003-09Registered2004-07-07Stopped2011-06Results posted2012-07-06

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Sponsor type
Industry
Conditions
Interstitial Cystitis
Interventions
Pentosan polysulfate sodium 100 mg; Placebo; Pentosan polysulfate sodium 100 mg
Participants
369
Sites
65
Countries
Canada, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.